PK
ProtoKinetix, Incorporated
PKTX · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $78.3K
P/E Ratio -
Div. Yield -
ROE 116.26%
Piotroski F-Score Weak
2/9Valuation
94 /100
Cheap P/S 1.61x
P/B 0.31x
P/E N/A
Growth
20 /100
Declining Book val. growth 1.04%
EPS growth N/A
Rev. growth N/A
Profitability
0 /100
Weak Gross margin 28.45%
Net margin 772.75%
Op. margin 746.74%
Quality
1 /100
Poor ROIC 145.16%
ROE 116.26%
ROA 78.76%
Debt
67 /100
Low Debt/Equity 0.00x
Current ratio 0.01x
Int. coverage N/A
Stability
61 /100
Moderate Beta 0.73x
EPS volatility 35.37%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na PKTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Michael Richard Guzzetta
Employees
5
Headquarters
Dalton